Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today announced that John Maslowski, vice president, scientific affairs of Fibrocell Science will present on Tuesday, October 7 at 2:30 p.m. PDT at the 4th Annual Partnering Forum, part of the Stem Cell Meeting on the Mesa to be held October 7-9 in La Jolla, California. Mr. Maslowski will discuss the company’s autologous fibroblast technology, and its therapeutic candidates in development focused on genetically-modified personalized biologics.
Help employers find you! Check out all the jobs and post your resume.
